<qa>  What is a STUDY OF BIND-014?A STUDY OF BIND-014 DOCETAXEL NANOPARTICLES FOR INJECTABLE SUSPENSION AS SECOND-LINE THERAPY FOR PATIENTS WITH KRAS POSITIVE OR SQUAMOUS CELL NON-SMALL CELL LUNG CANCER: 